Search - tctmd.com

Displaying 141 - 160 of 164

Sort: Relevancy | Date

News Industry News

Medtronic Sutureless Heart Valve First to Show Five-Year Safety and Efficacy Outcomes

April 29, 2014

News Daily News

No Long-term Decline in Cognitive Performance After TAVR

Jason Kahn

October 25, 2013

News Daily News

Innovative Stent-Grafts Safe, Feasible for High-Risk Complex Aortic Aneurysms

Yael L. Maxwell

October 25, 2013

News Daily News

PARTNER Substudy Looks at Echocardiographic Differences Between TAVR, Surgery

Caitlin E. Cox

April 26, 2013

News Conference News ACC 2013

ACC/i2 2013: Controversy, Late Breaking Trial News Dominate Busy Meeting

L.A. McKeown

March 14, 2013

News Conference News ACC 2013

PARTNER: TAVR Still Safe, Effective at 3 Years, Stroke Risk Diminished

Yael L. Maxwell

March 11, 2013

News Daily News

Myocardial Injury Common with TAVR, Prognostic Only If Accompanied by AKI

Yael L. Maxwell

March 09, 2013

News Daily News

ROCKET AF Analysis Looks at Stroke Risk After Stopping Anticoagulation

February 04, 2013

News Conference News TCT 2012

Review of TAVR Use Offers Significant Advances, Positive Outcomes

October 22, 2012

News Daily News

Frailty Index Best at Predicting Functional Decline After TAVR

Yael L. Maxwell

September 28, 2012

News Daily News

Cerebral Embolization During TAVR Comparable Across Access Routes, Devices

August 24, 2012

News Industry News

St. Jude Medical Launches New Trifecta Heart Valve in Japan

April 17, 2012

News Daily News

Single-Center Studies Build Case for Venous Angioplasty in Multiple Sclerosis

Caitlin E. Cox

April 05, 2012

News Daily News

TCTMD’s Top 10 Most Popular News Stories From 2011

Jason Kahn

March 08, 2012

News Daily News

Repositionable Valve Yields Promising 2-Year TAVR Results

December 06, 2011

News Conference News

Complications After TAVR: Manageable, But Important to Consider

November 09, 2011

News Conference News

TAVR Bioprosthesis Safe, Effective at 1 Year

November 07, 2011

News Industry News

Study Shows Medtronic CoreValve® System Efficacy and Durability Through Four Years in Longest-Term Industry Data Available

August 28, 2011

News Industry News

St. Jude Medical Announces FDA Approval of Trifecta Valve

April 20, 2011

News Daily News

TAVI with CoreValve Effective, Safe at 2-Years, Though Mortality a Concern

Leah Lawrence

April 11, 2011

Advertisement

Medtronic Sutureless Heart Valve First to Show Five-Year Safety and Efficacy Outcomes

No Long-term Decline in Cognitive Performance After TAVR

Innovative Stent-Grafts Safe, Feasible for High-Risk Complex Aortic Aneurysms

PARTNER Substudy Looks at Echocardiographic Differences Between TAVR, Surgery

ACC/i2 2013: Controversy, Late Breaking Trial News Dominate Busy Meeting

PARTNER: TAVR Still Safe, Effective at 3 Years, Stroke Risk Diminished

Myocardial Injury Common with TAVR, Prognostic Only If Accompanied by AKI

ROCKET AF Analysis Looks at Stroke Risk After Stopping Anticoagulation

Review of TAVR Use Offers Significant Advances, Positive Outcomes

Frailty Index Best at Predicting Functional Decline After TAVR

Cerebral Embolization During TAVR Comparable Across Access Routes, Devices

St. Jude Medical Launches New Trifecta Heart Valve in Japan

Single-Center Studies Build Case for Venous Angioplasty in Multiple Sclerosis

TCTMD’s Top 10 Most Popular News Stories From 2011

Repositionable Valve Yields Promising 2-Year TAVR Results

Complications After TAVR: Manageable, But Important to Consider

TAVR Bioprosthesis Safe, Effective at 1 Year

Study Shows Medtronic CoreValve® System Efficacy and Durability Through Four Years in Longest-Term Industry Data Available

St. Jude Medical Announces FDA Approval of Trifecta Valve

TAVI with CoreValve Effective, Safe at 2-Years, Though Mortality a Concern

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content